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Homeostatic synapticplasticity is important formain-
taining stability of neuronal function, but heteroge-
neous expression mechanisms suggest that distinct
facets of neuronal activity may shape the manner in
which compensatory synaptic changes are imple-
mented. Here, we demonstrate that local presynaptic
activity gates a retrograde form of homeostatic
plasticity induced by blockade of AMPA receptors
(AMPARs) in cultured hippocampal neurons. We
show that AMPAR blockade produces rapid (<3 hr)
protein synthesis-dependent increases in both
presynaptic and postsynaptic function and that the
induction of presynaptic, but not postsynaptic,
changes requires coincident local activity in presyn-
aptic terminals. This ‘‘state-dependent’’ modulation
of presynaptic function requires postsynaptic release
of brain-derived neurotrophic factor (BDNF) as a
retrograde messenger, which is locally synthesized
in dendrites in response to AMPAR blockade. Taken
together, our results reveal a local crosstalk between
active presynaptic terminals and postsynaptic
signaling that dictates the manner by which homeo-
static plasticity is implemented at synapses.
INTRODUCTION
Activity-dependent forms of synaptic plasticity such as long-
term potentiation (LTP) and long-term depression (LTD) have
long been considered primary candidates for cellular mecha-
nisms of information storage, but only over the last decade has
there been wide interest in understanding how neural circuits
maintain stability by offsetting the destabilizing nature of these
synaptic modifications. It is now known that central neurons
have the potential to adapt to changing activity levels by invoking
compensatory changes in synaptic function (Davis, 2006; Turri-
giano, 2008; Pozo and Goda, 2010). In central neurons, such
homeostatic forms of synaptic plasticity are typically studied inNethe context of chronic perturbations of neural activity in networks
of cultured neurons, where persistent activity elevation or
suppression is met with a gradual weakening or strengthening
of synaptic efficacy, respectively (Turrigiano et al., 1998; O’Brien
et al., 1998).
Recent studies have revealed that homeostatic synaptic plas-
ticity is associated with heterogeneous expression mechanisms.
During activity deprivation, homeostatic changes at excitatory
synapses can manifest as an increase in postsynaptic sensitivity
to glutamate (Turrigiano et al., 1998; O’Brien et al., 1998;
Wierenga et al., 2005; Sutton et al., 2006), an increase in presyn-
aptic neurotransmitter release (Murthy et al., 2001; Burrone et al.,
2002), or some combination of the two (Thiagarajan et al., 2005;
Gong et al., 2007). Although cell type or developmental age
(Wierenga et al., 2006; Echegoyen et al., 2007) may contribute
to these differences, recent evidence suggests that the same
synapse can exhibit different forms of synaptic compensation
tuned to distinct facets of neural activity. Chronic action potential
(AP) blockade with tetrodotoxin (TTX) typically induces a slow
(>12 hr) scaling of postsynaptic function (Turrigiano et al.,
1998; Sutton et al., 2006) that is associated with a synaptic
accumulation of AMPA-type glutamate receptors (AMPARs)
that contain the GluA2 subunit (Wierenga et al., 2005; Sutton
et al., 2006; Ibata et al., 2008). By contrast, coincident blockade
of APs and miniature synaptic events induces a greatly acceler-
ated homeostatic increase in postsynaptic function (Sutton et al.,
2006) mediated by de novo dendritic synthesis of GluA1 and the
incorporation of GluA2-lacking AMPARs at synapses (Sutton
et al., 2006; Aoto et al., 2008; see also, Ju et al., 2004). Chronic
(24 hr) AMPAR blockade (without coincident AP blockade)
also induces postsynaptic compensation that requires synaptic
incorporation of GluA2-lacking AMPARs, but importantly, an
increase in presynaptic release probability is also observed
(Thiagarajan et al., 2005; Gong et al., 2007). Furthermore,
at the Drosophila neuromuscular junction, Frank et al. (2006)
also observed a rapid homeostatic adjustment of synaptic effi-
cacy when miniature events were blocked, but these changes
were observed in quantal content and were thus reflective
of a presynaptic expression mechanism. Hence, although
there is convergent support for the role of miniature synaptic
events in homeostatic synaptic plasticity, it is still unclear why
direct blockade of excitatory postsynaptic drive can recruituron 68, 1143–1158, December 22, 2010 ª2010 Elsevier Inc. 1143
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BDNF as a State-Dependent Retrograde Messengercorresponding presynaptic changes in some circumstances, but
not others.
A defining feature of synapses in the neocortex and hippo-
campus is a tight correspondence of pre- and postsynaptic
structure indicative of strong functional matching on either side
of the synapse. Given that many forms of both homeostatic
and Hebbian synaptic plasticity are initially mediated by func-
tional changes that are restricted to the postsynaptic compart-
ment, there must be some mechanism that can recruit
corresponding changes in presynaptic function in a retrograde
fashion. Indeed, a number of studies have documented such
retrograde influences on presynaptic structure and function
induced by chronic manipulations of postsynaptic activity and/
or function (e.g., Paradis et al., 2001; Pratt et al., 2003; Branco
et al., 2008). These observations thus raise the question of
whether homeostatic adjustment of synapse function is influ-
enced not only by the severity of activity deprivation, but also
by the extent to which neurons retain certain activity-dependent
signaling capabilities.
Here, we identify a retrograde signaling mechanism in hippo-
campal neurons that coordinates homeostatic changes in pre-
and postsynaptic function. We show that blocking excitatory
synaptic drive through AMPARs not only produces faster post-
synaptic compensation compared with AP blockade, it also
induces retrograde enhancement of presynaptic function that
is prevented by coincident AP blockade. This sensitivity to AP
blockade reflects state-dependent gating of these presynaptic
changes by local activity in presynaptic terminals. Finally, we
demonstrate that the local crosstalk between postsynaptic
activity and presynaptic function is mediated by local dendritic
release of BDNF as a retrograde messenger, which is required
downstream of protein synthesis for the presynaptic changes
induced by AMPAR blockade. Our results thus demonstrate
a link between local control of protein synthesis in dendrites
and activity-dependent transynaptic modulation of presynaptic
function.
RESULTS
AMPAR Blockade Induces State-Dependent Changes
in Presynaptic Function
We first compared the homeostatic regulation of synapse func-
tion induced by chronic (24 hr) AP blockade (2 mM TTX), chronic
AMPAR blockade (10 mM NBQX), or a combination of the two
(NBQX+TTX). Both AP and AMPAR blockade profoundly
decrease excitatory synaptic drive, but each spares a distinct
facet of neuronal activity: AP blockade spares miniature neuro-
transmission, whereas AMPAR blockade spares the capacity
for neurons to spontaneously fire APs (confirmed by loose-patch
recordings; data not shown). Consistent with previous studies,
we found that chronic AP blockade produced a significant
increase in mEPSC amplitude, without a corresponding change
in mEPSC frequency (Figures 1A–1C). Likewise, chronic AMPAR
blockade produced a significant increase in mEPSC amplitude,
revealed upon NBQX washout, but also a significant increase
in mEPSC frequency as reported by others (Murthy et al.,
2001; Thiagarajan et al., 2005; Gong et al., 2007). Interestingly,
when coapplied over 24 hr, TTX specifically prevented the1144 Neuron 68, 1143–1158, December 22, 2010 ª2010 Elsevier Incincrease in mEPSC frequency induced by NBQX, without
affecting the increase in mEPSC amplitude (Figures 1A–1C).
Although coincident TTX application prevented the induction of
NBQX-dependent changes in mEPSC frequency, it did not
prevent the expression of these changes—the increase in
mEPSC frequency induced by NBQX alone persisted for at least
60 min with continuous presence of TTX in the recording ringer.
These results suggest that chronic AP blockade is effective in es-
tablishing compensatory postsynaptic changes, and it also
appears to specifically prevent the development of compensa-
tory presynaptic changes.
Given that previous studies have demonstrated rapid forms of
homeostatic plasticity induced by direct blockade of synaptic
activity (Sutton et al., 2006; Frank et al., 2006), we next examined
whether the changes in mEPSC amplitude or frequency that
accompany AMPAR blockade develop with different kinetics
than the scaling of mEPSC amplitude induced by AP blockade
alone. Confirming previous observations (Turrigiano et al.,
1998; Sutton et al., 2006), we found that a relatively brief period
of AP blockade (2 mM TTX, 3 hr) was insufficient to alter mEPSC
frequency or amplitude (Figures 1D–1F). However, brief periods
of AMPAR blockade (40 mM CNQX, 3 hr) induced significant
increases in both mEPSC amplitude and frequency (Figures
1D–1F), consistent with an increase in both pre- and postsyn-
aptic function. Again, we found that coincident AP blockade
during induction (TTX+CNQX, 3 hr) specifically prevented the
increase in mEPSC frequency without altering the scaling of
mEPSC amplitude induced by brief AMPAR blockade (Figures
1D–1F). These results suggest that AMPAR blockade recruits
a ‘‘state-dependent’’ increase in presynaptic release proba-
bility—the induction of these presynaptic changes requires that
neurons retain the capacity for AP firing.
The state-dependent increase in mEPSC frequency observed
after AMPAR blockade could reflect a persistent increase in
presynaptic function. Alternatively, it could reflect a postsynaptic
unsilencing of AMPAR lacking synapses, given that enhanced
AMPAR expression at synapses is associated with homeostatic
increases in synapse function (O’Brien et al., 1998; Wierenga
et al., 2005; Thiagarajan et al., 2005; Sutton et al., 2006).
However, we found that AMPAR blockade enhances surface
expression of the AMPAR subunit GluA1 at PSD95-labeled excit-
atory synapses to a similar extent regardless of whether spiking
was permitted or prevented with coincident TTX application
(Figures 1G and 1H and Figure S1 available online). To monitor
changes in presynaptic function directly, we examined the
activity-dependent uptake of an antibody against the lumenal
domain of synaptotagmin-1 (syt-lum) at excitatory synapses
marked by immunoreactivity for the vesicular glutamate trans-
porter (vglut1). Syt-lum uptake is still visible under stringent
permeabilization conditions necessary to efficiently colabel
synaptic sites in the same cells, and thus provides a direct
measure of presynaptic function where overall synaptic density
is internally controlled. We first validated the activity-dependent
nature of syt-lum uptake at synaptic sites by using direct depo-
larization of synaptic terminals (60 mM K+), and confirmed that
the AP-independent uptake of syt-lum is synaptic (Figure S2).
We then assessed excitatory presynaptic function after 3 hr
AMPAR blockade using synaptic syt-lum uptake as a read-out..
sy
t u
pt
ak
e 
(p
ro
p 
vg
lu
t1
 sy
na
ps
es
)
Co
ntr
ol
CN
QX TT
X
TT
X+
CN
QX
Co
ntr
ol
CN
QX
CT
x/A
Tx
C/
AT
x+
CN
QX
* *
Co
ntr
ol
CN
QX TT
X
TT
X+
CN
QX
Sy
na
pt
ic
 sG
lu
R
1 
(%
 c
on
tro
l)
G H
Control
CNQX
TTX
TTX +
CNQX
vglut1 sytI Merge
255
0
J
Control
CNQX
TTX
TTX +
CNQX
255
0
PSD-95 sGluR1 Merge
* *
A
*
Co
ntr
ol
NB
QX TT
X
TT
X+
NB
QX
Co
ntr
ol
NB
QX TT
X
TT
X+
NB
QX
B C
D
m
EP
SC
 A
m
pl
itu
de
 (p
A
)
* *
Co
ntr
ol
CN
QX TT
X
TT
X+
CN
QX
E
CNQX
CNQX
TTX+
Con
m
EP
SC
 F
re
qu
en
cy
 (H
z)
Co
ntr
ol
CN
QX TT
X
TT
X+
CN
QX
F
*
m
EP
SC
 A
m
pl
itu
de
 (p
A
)
m
EP
SC
 F
re
qu
en
cy
 (H
z)* * *
20 pA
NBQX
NBQX
TTX+
Con
100 ms 20 pA
100 ms
K
Inter-pulse Interval (ms)
PP
F 
(%
 in
cr
ea
se
 in
 E
PS
C
2
0 200 400 600 800 1000
-5
0
10
20
30
40
 
Control
CNQX (3hr)
TTX+CNQX (3hr)
Control CNQX (3hr) TTX+CNQX (3hr)
L
50 ms
25 pA *
Figure 1. AMPAR Blockade Induces a State-
Dependent Enhancement of Presynaptic function
(A–C) Representative recordings (A) and mean (+ SEM)
mEPSC amplitude (B) and frequency (C) of experiments
(27–40 DIV) from the following conditions (24 hr): Control
(n = 13), 10 mM NBQX (n = 9), 2 mM TTX (n = 10), and TTX+
NBQX (n = 8). Twenty-four hour NBQX increases both
mEPSC amplitude and frequency (*p < 0.05, relative to
control); AP blockade prevents the increase in mEPSC
frequency induced by AMPAR blockade, but not changes
in mEPSC amplitude.
(D–F) Representative recordings (D) and mean (+ SEM)
mEPSC amplitude (E) and frequency (F) of experiments
(21–38 DIV) from the following conditions (3 hr): Control
(n = 10), 40 mM CNQX (n = 12), 2 mM TTX (n = 10), and
TTX+CNQX (n = 11). Brief AMPAR blockade induces
a significant (*p < 0.05, relative to control) increase in
both mEPSC amplitude and frequency; AP blockade
prevents the increase in mEPSC frequency induced by
AMPAR blockade, but not changes in mEPSC amplitude.
(G) Representative examples and (H) mean (+SEM)
normalized surface GluA1 expression at excitatory
synapses (21–40 DIV) from the following conditions
(3 hr): Controls (n = 46), CNQX (n = 44), TTX (n = 48), or
CNQX+TTX (n = 46). Brief AMPAR blockade significantly
(*p < 0.05, relative to control) enhances postsynaptic
surface GluA1 expression in the presence or absence of
background spiking.
(I and J) Representative examples and mean (+SEM)
proportion of vglut1-positive excitatory presynaptic termi-
nals with corresponding syt-lum signal from the indicated
treatment groups (DIV 37–40). Left to right n = 54, 49, 52,
50, 64, 68, 64, and 67 images. Brief AMPAR blockade
significantly (*p < 0.05, relative to control) enhances
synaptic syt-lum uptake that is prevented by coincident
AP (+TTX) or P/Q/N-Ca2+ channel (+CTx/ATx) blockade.
(K and L) Example traces (K) and mean (±SEM) (L) paired-
pulse facilitation (PPF), defined as the percent increase in
peak amplitude of EPSC2 relative to EPSC1 at different
inter-pulse intervals. AMPAR blockade (CNQX alone; n =
29 neurons) produced a significant (*p < 0.05, relative to
control; n = 29 neurons) decrease in PPF; co-application
of TTX during AMPAR blockade (n = 29 neurons) restored
PPF to control levels. The dashed line represents peak
amplitude of EPSC1. Scale bars represent 25 pA, 50 ms.
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BDNF as a State-Dependent Retrograde MessengerPrior to labeling, neuronswere exposed to 2 mMTTX for 15min to
isolate spontaneous neurotransmitter release. As a measure of
presynaptic function, we quantified the percentage of vglut1-
positive excitatory synaptic terminals with accompanying
syt-lum staining. We found that 3 hr AMPAR blockade enhanced
presynaptic function relative to untreated controls and neurons
experiencing a blockade of APs alone with TTX (Figures 1I and
1J and Figure S3). Moreover, coincident blockade of both
AMPARs and spiking prevented the increase in syt-lum uptake,
similar to the state-dependent enhancement of mEPSC fre-
quency revealed by electrophysiology. A similar pattern of
results was observed with presynaptic FM4-64X labeling (Fig-
ure S3). These effects on presynaptic function were not associ-
ated with a change in overall density of excitatory synapses
(Figure S3), illustrating that AMPAR blockade regulates the func-
tion of existing excitatory synaptic terminals.
Although AMPAR blockade removes excitatory synaptic drive,
it does not prevent neurons from spiking spontaneously (data notNeshown), raising the possibility that state-dependent changes in
presynaptic function require presynaptic spiking. To test this
possibility, we used a cocktail of 1 mM u-conotoxin GVIA and
200 nM u -agatoxin IVA; CTx/ATx) to block P/Q and N-type
Ca2+ channels that are localized to presynaptic terminals and
normally support AP-mediated neurotransmission (Wheeler
et al., 1994). We found that, like TTX treatment, coincident
P/Q/N-type Ca2+ channel blockade completely prevented the
increase in synaptic syt-lum uptake induced by 3 hr AMPAR
blockade (Figure 1J). In a parallel set of experiments, we similarly
found that coincident CTx/ATx treatment specifically prevented
the increase in mEPSC frequency induced by AMPAR blockade
(mean ± SEM mEPSC frequency, control = 1.43 ± 0.26 Hz;
3hr CNQX = 3.37 ± 0.58 Hz, p < 0.05; CNQX + CTx/ATx =
1.15 ± 0.11 Hz, NS; n = 12, 10, 10; data not shown). Finally,
we also examined whether the changes in presynaptic func-
tion reflected by spontaneous synaptic vesicle exocytosis
extended to changes in evoked release by washing out CNQXuron 68, 1143–1158, December 22, 2010 ª2010 Elsevier Inc. 1145
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BDNF as a State-Dependent Retrograde Messenger(or CNQX+TTX) after 3 hr and measuring paired-pulse facilitation
(PPF). As expected for an increase in evoked release probability,
we found that AMPAR blockade significantly inhibited PPF
whereas coincident TTX application with CNQX fully restored
PPF to control levels (Figures 1K and 1L). Together, these results
demonstrate that AMPAR blockade induces two qualitatively
distinct compensatory changes at synapses: an increase in
postsynaptic function that is induced regardless of spiking
activity and a state-dependent enhancement of presynaptic
function that requires coincident presynaptic activity.
NMDAR Blockade Induces Rapid Postsynaptic,
but Not Presynaptic, Compensation
We next examined whether the homeostatic changes in presyn-
aptic function are driven by AMPAR blockade specifically, or
whether they are also evident after NMDAR blockade. We first
addressed this issue by using mEPSC recordings after 3 hr
AMPAR blockade (10 mM NBQX) or 3 hr NMDAR blockade
(50 mM APV). We found that whereas both AMPAR and NMDAR
blockade induced rapid postsynaptic compensation reflected
as an increase in mEPSC amplitude, significant changes in
mEPSC frequency emerged after blockade of AMPARs, but
not NMDARs (Figure S4). Similarly, 3 hr NBQX treatment signifi-
cantly enhanced syt-lum uptake at synapses, whereas APV
treatment did not (Figure S4). Since rapid postsynaptic compen-
sation induced by NMDAR blockade is mediated by the synaptic
recruitment of GluA1 homomeric receptors (Sutton et al., 2006;
Aoto et al., 2008), we also examined the functional role of
GluA1 homomers after brief (3 hr) AMPAR blockade. We found
that after 3 hr CNQX treatment, addition of 1-Napthylacetylsper-
mine (Naspm, a polyamine toxin that specifically blocks
AMPARs that lack the GluA2 subunit) during recording reverses
the increase in mEPSC amplitude back to control levels, while
having no effect in control neurons (Figure S5). Interestingly,
although Naspm also decreased mEPSC frequency in a subset
of neurons recorded following AMPAR blockade, mEPSC
frequency in the presence of Naspm remained significantly
elevated relative to control neurons (Figure S5). The differential
sensitivity of mEPSC frequency and amplitude to both NMDAR
blockade and Naspm suggests that the presynaptic and
postsynaptic changes are induced in parallel and are at least
partially independent. These results suggest that whereas similar
postsynaptic adaptations accompany blockade of AMPARs or
NMDARs, the compensatory presynaptic changes are uniquely
sensitive to AMPAR activity.
Local Activity at Presynaptic Terminals Is Required
for Retrograde Modulation of Presynaptic Function
Does the requirement for either spiking or voltage-gated Ca2+
channels reflect a global network/cell-wide effect or does local
activity at presynaptic terminals gate such changes? To distin-
guish between these possibilities, we examined syt-lum uptake
after local microperfusion of either TTX or P/Q/N-type Ca2+
channel blockers coupled with global AMPAR blockade (bath
application of 20 mM CNQX). Local perfusion was initiated, and
5 min later, CNQX was bath-applied for 2 hr (total local perfusion
time of 125 min). Cells were then treated with 2 mM TTX, live-
labeled with syt-lum, fixed, and processed for immunostaining1146 Neuron 68, 1143–1158, December 22, 2010 ª2010 Elsevier Incagainst vglut1. As before, we assessed presynaptic function by
quantifying the proportion of vglut1-positive excitatory synapses
that were also labeled with syt-lum. Although local perfusion of
vehicle during global AMPAR blockade did not affect the
increase in syt-lum uptake, local administration of either TTX or
CTx/ATx produced a significant decrease in presynaptic syt
uptake in the perfused area relative to apposed terminals on
neighboring sections of the same dendrite (Figure 2). As an
internal control, no differences were observed in vglut1 density
(Figure 2C) or vglut 1 particle intensity (data not shown) in the
perfused area relative to terminals on apposing dendritic
segments outside of the perfusion area. The local decrease in
presynaptic release probability induced by CTx/ATx required
coincident AMPAR blockade, given that no changes in syt-lum
uptake were observed in the treated area when bath CNQX
was omitted (Figure 2D); similar results were found in control
experiments using local TTX treatment in the absence of
CNQX (Bath Vehicle + local TTX, mean ± SEM proportion of vglut
particles with syt-lum, untreated areas = 0.31 ± 0.04; treated
area = 0.33 ± 0.06, NS, n = 5 dendrites, 3 neurons). Taken
together, these data indicate that AMPAR blockade induces
retrograde enhancement of presynaptic function that is gated
by local activity in presynaptic terminals.
Postsynaptic BDNF Release Is Required for
Compensatory Presynaptic, but Not Postsynaptic
Changes
How does postsynaptic activity blockade lead to sustained
increases in presynaptic function? Acute BDNF application can
rapidly drive increases in presynaptic function (e.g., Alder
et al., 2005; Zhang and Poo, 2002), and extended BDNF expo-
sure can induce structural changes at presynaptic terminals
(e.g., Tyler and Pozzo-Miller, 2001), suggestive of sustained
changes in presynaptic release that may persist when BDNF is
no longer present. Consistent with the notion that endogenous
BDNF is required for the sustained changes in presynaptic func-
tion induced by AMPAR blockade, we found that scavenging
endogenous extracellular BDNF (with TrkB-Fc; 1 mg/ml) or block-
ing downstream receptor tyrosine kinase signaling (with the Trk
inhibitor k252a; 100 nM) during AMPAR blockade both specifi-
cally block the increase in syt-lum uptake (Figures 3A and 3B),
but do not produce changes in overall synapse density (Fig-
ure S6). Importantly, neither TrkB-Fc nor k252a affected syt-
lum uptake in neurons when CNQX and TTX are coapplied, indi-
cating that these effects are specific for the state-dependent
changes in presynaptic function. Interestingly, sequestering
BDNF did not affect the enhancement of surface GluA1 expres-
sion at synaptic sites during AMPAR blockade (Figures 3C and
3D). Similarly, we found that coapplication of TrkB-Fc with
CNQX completely prevents the state-dependent increase in
mEPSC frequency induced by AMPAR blockade, but does not
reduce the increase in mEPSC amplitude (Figures 3E–3G), sug-
gesting that endogenous BDNF-driven signaling appears to play
a specific role in presynaptic compensation. To confirm that
postsynaptic BDNF is necessary for the enhancement of presyn-
aptic function induced by AMPAR blockade, we transfected
neurons with shRNAs against BDNF or a scrambled control
shRNA; transfected neurons were identified by RFP expression,.
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Figure 2. Local Presynaptic Activity Gates Retrograde Enhancement of Presynaptic Function Induced by AMPAR Blockade
(A) Representative DIC image (24 DIV) with superimposed CTx/ATx perfusion spot (red) and syt-lum and vglut1 staining from the same neuron.
(B) Linearized dendrite indicated by the arrow shown in (A) with corresponding syt-lum and vglut1 staining registered to the perfusion area (red). The scale bar
represents 30 mm and 10 mm in (A) and (B), respectively.
(C and D) Analysis of group data. On the abscissa, positive and negative values indicate, respectively, segments distal and proximal from the treated area.
(C) Mean (±SEM) normalized vglut1 density in treated and untreated dendritic segments; local perfusion did not affect synaptic density.
(D) Mean (±SEM) proportion of vglut1-positive synapses with corresponding syt-lum signal in treated and untreated dendritic segments. Coincident AMPAR
blockade (20 mMCNQX, 2 hr) significantly (*p < 0.05) increased syt uptake in the treated area in neurons locally treated with vehicle relative to those locally treated
with TTX or CTx/ATx. For the groups indicated from top to bottom in (D), n = 10 dendrites from 7 cells; 12 dendrites from 8 cells; 14 dendrites from 10 cells; and 11
dendrites from 7 cells (21–35 DIV).
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BDNF as a State-Dependent Retrograde Messengerexpressed from an independent promoter in each shRNA
plasmid. Two distinct BDNF shRNAs effectively knocked down
BDNF expression relative to the scrambled control, as revealed
by BDNF immunocytochemistry 24 hr after transfection (Figures
3H–3J). The low transfection efficiency (<1%of neurons) allowed
us to examine selective loss of BDNF from a postsynaptic neuron
surrounded by untransfected neurons that are otherwise unper-
turbed. Hence, mEPSC recordings from transfected neurons
revealed that postsynaptic BDNF knockdown (21 hr prior to
AMPAR blockade) did not alter the enhancement of mEPSC
amplitude but selectively blocked the increase in mEPSC fre-
quency after brief periods of AMPAR blockade (3 hr CNQX, Fig-
ures 3K–3M). Taken together, these results suggest that BDNF
release from the postsynaptic neuron is essential for homeo-
static retrograde enhancement of presynaptic function.
BDNF Is Sufficient to Drive State-Dependent Changes
in Presynaptic Function
We next examined whether BDNF exposure was sufficient to
mimic state-dependent enhancement of presynaptic function
observed after AMPAR blockade. We treated neurons withNevarying durations and concentrations of human recombinant
BDNF, then washed off BDNF and assayed spontaneous syt-
lum uptake. We found that direct BDNF application induces
sustained changes in presynaptic function in a time- and
concentration-dependent manner, whereas coapplication of
TTX or CTx/ATx with BDNF completely prevents this effect
(Figures 4A–4C). These changes in function were not associated
with overall changes in synapse density (Figure S6), suggesting
that like AMPAR blockade, BDNF enhances the function of exist-
ing presynaptic terminals. By contrast, BDNF application had no
significant effect on surface GluA1 expression at synapses (Fig-
ure S6), suggesting a selective presynaptic role. Additionally, we
found that BDNF application (250 ng/ml, 10 min) enhanced
mEPSC frequency within minutes, but these changes rapidly
reversed upon BDNF washout (data not shown). By contrast,
longer exposure to BDNF (250 ng/ml, 2 hr) induced a robust
and sustained increase in mEPSC frequency, which was pre-
vented by AP or P/Q/N-type Ca2+ channel blockade coincident
with BDNF exposure (Figures 4D and 4E). Because both AMPAR
blockade and BDNF treatment induce sustained increases in
mEPSC frequency, we next examined whether these effectsuron 68, 1143–1158, December 22, 2010 ª2010 Elsevier Inc. 1147
AControl
CNQX
C
Co
ntr
ol
CN
QXTT
X
TT
X+
CN
QX
Co
ntr
ol
CN
QXTT
X
TT
X+
CN
QX
*
* *
*
+ trkB-Fc
Sy
na
pt
ic
 sG
lu
R
1 
(%
 c
on
tro
l)
*
m
EP
SC
 A
m
pl
itu
de
 (p
A
)
*
m
EP
SC
 F
re
qu
en
cy
 (H
z)
E GF
Con CNQX
Alone
TTX TTX+
CNQXAlone
Con CNQX
Alone
TTX TTX+
CNQXAlone
**
*Control
CNQX
CNQX + trkB-Fc
k252a
CNQX +
trkB-Fc
CNQX +
vglut syt(lum) Merge
** **
sy
t u
pt
ak
e 
(p
ro
p 
V
G
lu
t1
 sy
na
ps
es
)
+ trkB-Fc + k252a
*
Co
ntr
ol
CN
QX TT
X
TT
X+
CN
QX
Co
ntr
ol
CN
QX TT
X
TT
X+
CN
QX
Co
ntr
ol
CN
QX TT
X
TT
X+
CN
QX
Control
CNQX
trkB-Fc
CNQX +
PSD95 sGluR1 Merge
B D
H
m
EP
SC
 A
m
pl
itu
de
 (p
A
)
m
EP
SC
 F
re
qu
en
cy
 (H
z)
Scrambled shRNA1 shRNA2
RFP
BDNF
CNQX: + + + + + +
Scr BDNF
shRNA1
BDNF
shRNA2
Scr BDNF
shRNA1
BDNF
shRNA2
Scr
shRNA1
Scr
shRNA1
+ CNQX
(3hr)
I
K
L M
J
N
or
m
al
iz
ed
 B
D
N
F 
 
ex
pr
es
si
on
N
or
m
al
iz
ed
 B
D
N
F 
 
ex
pr
es
si
on
Cell Body Dendrite
* *
*
*
Scr BDNF
shRNA1
BDNF
shRNA2
Scr BDNF
shRNA1
BDNF
shRNA2
Figure 3. BDNF Release and Signaling Are Required for Presynaptic, but Not Postsynaptic, Compensation Induced by AMPAR Blockade
(A and B) Representative examples (A) and mean (+ SEM) (B) syt-lum uptake from experiments (25 DIV) where the indicated treatment groups were examined
either alone (n = 34 images/group) or cotreated (30 min prior) with trkB-Fc (1 mg/ml; n = 38 images/group) or k252a (100 nM; n = 24 images/group). Scavenging
extracellular BDNF (trkB-Fc) or blocking BDNF-induced signaling (k252a) each blocked enhanced syt-lum uptake induced by AMPAR blockade (*p < 0.05, rela-
tive to control).
(C and D) Representative examples (C) and mean (+ SEM) (D) normalized synaptic sGluA1 expression in the indicated groups (25 DIV). For the groups indicated
from left to right, n = 32, 30, 32, 31, 31, 32, 32, and 32 images. BDNF is not required for enhanced synaptic GluA1 expression after AMPAR blockade. Scale bars
represent 5 mm and 10 mm in (A) and (C), respectively.
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BDNF as a State-Dependent Retrograde Messengerwere additive. Treating neurons with BDNF for the last 2 hr of
AMPAR blockade produced no greater increase in mEPSC
frequency than observed in either condition alone (Figures 4F
and 4G), demonstrating that the sustained increase in presyn-
aptic function induced by CNQX treatment occludes such
enhancement induced by direct BDNF application. Finally, to
examine whether this role of BDNF is local or more global, we
locally scavenged BDNF (via restricted perfusion of TrkB-Fc)
during AMPAR blockade (120 min CNQX) and found that the
increase in syt-lum uptake was disrupted at presynaptic termi-
nals in the treated area; in the absence of AMPAR blockade
(bath vehicle), local TrkB-Fc had no effect (Figure S7).
Conversely, direct local application of BDNF (250 ng/ml, 60 min)
induced a selective increase in syt-lum uptake at terminals in
the treated area, relative to untreated terminals terminating on
the same dendrite (Figure S7). Taken together, these results
suggest a model whereby AMPAR blockade triggers dendritic
BDNF release, which drives retrograde enhancement of presyn-
aptic function selectively at active presynaptic terminals.
Retrograde Enhancement of Presynaptic Function
Requires New BDNF Synthesis
Previous studies have demonstrated that rapid postsynaptic
compensation at synapses induced by blocking miniature trans-
mission is protein synthesis dependent (Sutton et al., 2006; Aoto
et al., 2008; see also, Ju et al., 2004), so we next examined
whether the rapid presynaptic or postsynaptic changes associ-
ated with AMPAR blockade require new protein synthesis. As
suggested by these earlier studies, we found that the rapid
increase in surface GluA1 expression at synapses induced either
by AMPAR blockade alone (3 hr CNQX) or AMPAR and AP
blockade (CNQX + TTX) is prevented by the protein synthesis
inhibitor anisomycin (40 mM, 30 min prior) (Figure 5A); a different
translation inhibitor emetine (25 mM, 30 min prior) similarly
blocked changes in sGluA1 induced by 3 hr CNQX treatment
(data not shown). We also found (Figure 5B) that the state-
dependent increase in syt-uptake induced by AMPAR blockade
was prevented by pretreatment (30 min prior to CNQX) with
either anisomycin (40 mM) or emetine (25 mM). To verify that these
changes in surface GluA1 expression and syt-lum uptake are
indicative of changes in postsynaptic and presynaptic function,
respectively, we examined the effects of anisomycin onmEPSCs
(Figures 5C and 5D). In addition to preventing the enhancement
of mEPSC amplitude, blocking protein synthesis prevented the
state-dependent increase in mEPSC frequency induced by
AMPAR blockade, suggesting that rapid homeostatic control
of presynaptic function also requires new protein synthesis.(E–G) Representative recordings (E) (scale bar, 20 pA; 200 ms) and mean (+ SEM
cated treatments either with orwithout 30min preincubation with 1 mg/ml trkB-Fc.
(n = 8, 8), and TTX+CNQX (n = 10, 9). Treatment with trkB-Fc blocked the increa
AMPAR blockade.
(H–J) Example images (H) and mean (+ SEM) normalized BDNF expression in ce
10 mm; *p < 0.05 versus scrambled control.
(K–M) Representative recordings (K) and mean (+ SEM) mEPSC amplitude (L) a
control shRNA (Scr) or shRNAs against BDNF. The scale bar represents 15 pA
(21–42 DIV) transfected with scrambled shRNA or shRNAs against BDNF. Pos
not amplitude) after AMPAR blockade (CNQX, 3 hr).
NeWe next examined whether BDNF acts upstream or down-
stream of translation to persistently alter presynaptic function.
BDNF has a well-recognized role in enduring forms of synaptic
plasticity via its ability to potently regulate protein synthesis
in neurons (Kang and Schuman, 1996; Takei et al., 2001;
Messaoudi et al., 2002; Tanaka et al., 2008), suggesting that
BDNF release might engage the translation machinery to induce
sustained changes in presynaptic function. If so, then like
AMPAR blockade, the ability of BDNF to drive sustained presyn-
aptic compensation should be prevented by protein synthesis
inhibitors. Alternatively, BDNF itself could be a target of new
protein synthesis and could thus act as a translation effector
induced by AMPAR blockade (e.g., Pang et al., 2004; Bekinsch-
tein et al., 2007). If the role of BDNF is downstream of translation;
it should recapitulate the enhancement of presynaptic function
even in the presence of protein synthesis inhibitors. Indeed, we
found that the time course and magnitude of syt-lum uptake at
excitatory synapses after BDNF treatment was virtually identical
in the presence or absence of protein synthesis inhibitors
(Figures 5E and 5F), despite the fact that these inhibitors
completely prevent such increases induced by AMPAR
blockade. These changes again were specific for the presyn-
aptic compartment, given that BDNF (250 ng/ml, 2 hr) failed to
alter postsynaptic surface GluA1 expression in the presence of
anisomycin (data not shown). Moreover, the increase in mEPSC
frequency induced by direct BDNF application was similarly
unaffected by blocking protein synthesis with either anisomycin
or emetine (Figures 5H and 5I). These results suggest that BDNF
acts downstream of protein synthesis to drive state-dependent
changes in presynaptic function.
Dendritic Synthesis of BDNF Accompanies AMPAR
Blockade
The results described above suggest that BDNF translation is
a critical step in establishing state-dependent enhancement of
presynaptic function during AMPAR blockade. To explore this
idea further, we examined whether AMPAR blockade alters
BDNF expression. Western blotting of hippocampal neuron
lysates after treatment with CNQX or APV demonstrated that
AMPAR, but not NMDAR, blockade induces a time- dependent
increase in BDNF expression (Figure 6A) that is blocked
by anisomycin (Figure 6B), indicating that BDNF expression is
upregulated by AMPAR blockade in a protein synthesis-
dependent manner. To examine whether BDNF expression
after AMPAR blockade was differentially altered in specific
sub-cellular compartments, we examined BDNF expression
colocalized with specific pre- and postsynaptic markers by) mEPSC amplitude (F) and frequency (G) in neurons (21–42 DIV) after the indi-
Results were for the indicated groups: control (n = 8, 10), CNQX (n = 11, 12), TTX
se in mEPSC frequency but not the increase in mEPSC amplitude induced by
ll bodies (I) and dendrites (J) of transfected neurons. The scale bar represents
nd frequency (M) in neurons (21–42 DIV) transfected with either a scrambled
, 400 ms. Mean (+ SEM) mEPSC amplitude (L) and frequency (M) in neurons
tsynaptic BDNF knockdown prevents the increase in mEPSC frequency (but
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Figure 4. BDNF Enhances Presynaptic Function in a State-Dependent Manner
(A and B) Representative examples (A) andmean (±SEM) (B) spontaneous syt-lum uptake from neurons (25–43 DIV) after incubationwith BDNF (250 ng/ml) for the
indicated times. Color-look up table indicates syt fluorescence intensity; the scale bar represents 10 mm. BDNF increased spontaneous syt-lum uptake at
synapses (*p < 0.05, relative to 0 min); coincident treatment with TTX or CTx/ATx completely prevents this effect.
(C) Mean (+ SEM) state-depdendent syt-lum uptake as a function of BDNF (2 hr) concentration (*p < 0.05 relative control).
(D and E) Representative recordings (D) (scale bar, 20 pA; 200ms) andmean (+ SEM) (E) mEPSC frequency in neurons (21–51 DIV) treated with BDNF (250 ng/ml,
2 hr) either alone or coincident with TTX or CTx/ATx. BDNF significantly (*p < 0.05 relative control) increases mEPSC frequency that is prevented by AP or P/Q/
N-Ca2+ channel blockade.
(F and G) Representative recordings (F) (scale bar, 15 pA; 200 ms) and mean (+ SEM) (G) mEPSC frequency in neurons (21–42 DIV) treated as follows: control
(n = 12), BDNF (250 ng/ml, 2 hr; n = 12), CNQX (40 mM, 3 hr; n = 12), and BDNF+CNQX (n = 8) prior to TTX application and mEPSC recording. Both BDNF and
CNQX produce a significant (*p < 0.05 relative control) increase inmEPSC frequency, but the combination of the two does not produce a significant additive effect.
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Figure 5. BDNF Acts Downstream of
Protein Synthesis to Enhance Presynaptic
Function Induced by AMPAR Blockade
(A) Mean (+ SEM) normalized synaptic sGluA1
expression in neurons (25–42 DIV) where protein
synthesis was blocked with 40 mM anisomycin
30 min prior to and throughout activity blockade.
For the groups left to right, n = 38, 38, 38, 34, 40,
44, 48, and 48 images. Brief AMPAR blockade or
brief AMPAR + AP blockade significantly (*p <
0.05, relative to control) enhances surface GluA1
expression at synapses in a protein synthesis-
dependent manner.
(B) Mean (±SEM) spontaneous syt-lum uptake
from neurons (21–34 DIV) after activity blockade
in the presence or absence of protein synthesis
inhibitors (30 min pretreatment). For the groups
left to right, n = 58, 60, 61, 60, 30, 32, 34, 32, 34,
36, 36, and 36 images. Brief AMPAR blockade
significantly (*p < 0.05, relative to control)
enhances synaptic syt-lum uptake in a protein
synthesis-dependent fashion.
(C and D) Mean (+ SEM) mEPSC amplitude (C) and
frequency (D) in neurons (21–42 DIV) undergoing
AP blockade (2 mM TTX, 3 hr), AMPAR blockade
(40 mM CNQX, 3 hr), or AMPAR + AP blockade
(3 hr). For the indicated groups: control (n = 12,
11 cell), CNQX (n = 10, 8), TTX (n = 9, 13), and
TTX + CNQX (n = 10, 10). AMPAR blockade
produced a significant (*p < 0.05, relative to
control) increase in mEPSC amplitude and
frequency; cotreatment with anisomycin blocked
both sets of changes in mEPSCs induced by
AMPAR blockade.
(E and F) Representative examples (E) and mean
(±SEM) (F) spontaneous syt-lum uptake from
neurons (24–40 DIV) after incubation with BDNF
(250 ng/ml) +/ 40 mM anisomycin or 25 mM
emetine (each 30 min prior to BDNF) for the indi-
cated times. BDNF induces a time-dependent
enhancement of presynaptic function (*p < 0.05,
relative to 0 min); the same magnitude and
temporal profile of BDNF-induced changes in syt
uptake is observed with coincident anisomycin
treatment.
(G) Mean (+ SEM) syt-lum uptake induced by
BDNF (250 ng/ml; 2 hr) in the presence or absence
of 40 mM anisomycin or 25 mM emetine (each
30 min prior to BDNF); *p < 0.05 relative to non-
BDNF control).
(H and I) Representative recordings (H) and mean
(+ SEM) (I) mEPSC frequency after BDNF applica-
tion (250 ng/ml; 2 hr) in the presence or absence of
protein synthesis inhibitors (neurons 21–34 DIV).
For the groups indicated left to right, n = 18, 11,
11, 7, 14, and 17 cells. The significant (*p < 0.05)
increase in mEPSC frequency induced by BDNF
is unaltered by protein synthesis inhibitors.
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BDNF as a State-Dependent Retrograde Messengerimmunocytochemistry. We found that the increase in BDNF
expression induced by AMPAR blockade was largely accounted
for by regulation in dendrites, given that MAP2-positive
dendrites exhibited a significant increase in BDNF expression
in neurons treated with CNQX (2 hr), whereas somatic expres-
sion of BDNF from these same cells was unchanged (FiguresNe6C–6G). Importantly, both dendritic and somatic MAP2 expres-
sion were similar between CNQX-treated neurons and controls.
These changes in dendritic BDNF expression were again
specific to AMPAR blockade, given that NMDAR blockade
(APV, 2 hr) failed to alter BDNF expression (Figure S8). In
a parallel series of experiments, we found that AMPAR blockadeuron 68, 1143–1158, December 22, 2010 ª2010 Elsevier Inc. 1151
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Figure 6. AMPAR Blockade Enhances Synthesis and Compartment-Specific Expression of BDNF
(A) Representative western blots and summary data from experiments (21–52 DIV) examining time-dependent regulation of BDNF expression in response to
40 mM CNQX (n = 7) or 50 mM APV (n = 5); *p < 0.05 relative to 0 min by chi square.
(B) Representative western blots and summary data in experiments (n = 6) where neurons (DIV 21–32) were treated with CNQX (40 mM, 60 min) +/ anisomycin
(40 mM, 30 min before) before harvesting; *p < 0.05 relative to CNQX + Aniso (t test).
(C) Representative examples of MAP2 and BDNF staining from a control neuron and one treated with CNQX (40 mM, 2 hr).
(D) BDNF expression in linearized somatic and dendritic segments from the cells shown in (C).
(E) 3D plot of relative pixel intensity for the linearized images shown in (D). In (C)–(E), fluorescence intensity given by color-look table; scale bar represents 20 mm.
Despite similar somatic BDNF expression, dendritic BDNF expression is increased after AMPAR blockade.
(F) Mean (+ SEM) expression of MAP2 and BDNF in somatic and dendritic compartments and BDNF expression in axons, normalized to average control values, in
neurons (25–36 DIV) treated as indicated. BDNF expression in dendrites was significantly (*p < 0.05, relative to control) enhanced by AMPAR blockade (n = 46)
relative to control neurons (n = 47), but somatic expression from these same cells was unchanged. MAP2 expression did not differ between groups. The increase
in dendritic BDNF was prevented by anisomycin (40 mM, 30 min prior to CNQX; n = 46 neurons/group). Axonal BDNF expression was unaltered by AMPAR
blockade (n = 42) relative to untreated controls (n = 41).
(G) Mean (+ SEM) dendritic expression of MAP2 and BDNF, normalized to the average control value, in control (untreated) neurons (n = 25) or those treated
with CNQX (40 mM, 2 hr; n = 31), CNQX + emetine (25 mM, 30min prior to CNQX; n = 22), or emetine alone (n = 22). BDNF expression in dendrites was significantly
(*p < 0.05, relative to control) enhanced by AMPAR blockade in a protein synthesis-dependent fashion (25-36 DIV).
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Figure 7. AMPAR Blockade Drives Dendritic BDNF
Synthesis
(A) Representative DIC image of a cultured hippocampal
neuron (DIV 21) with superimposed emetine (25 mM) perfu-
sion spot (red) and the same neuron after retrospective
staining for BDNF andMAP2 from an experiment including
coincident AMPAR blockade (bath 40 mM CNQX, 60 min).
BDNF/MAP2 fluorescence intensity indicated by color
look-up table; the scale bar represents 20 mm.
(B) Linearized dendrite indicated by the arrow cell shown in
(A) with corresponding BDNF and MAP2 staining regis-
tered to the perfusion area (red).
(C) 3D plot of fluorescence intensity for the dendrites
shown in (B) relative to the perfusion area; a clear decrease
in BDNF expression in the treated area is apparent.
(D) Mean (±SEM) normalized BDNF/MAP2 expression in
treated and untreated dendritic segments from the indi-
cated groups (21–31 DIV); all data are expressed relative
to the average value in untreated segments. On the ab-
scissa, positive and negative values indicate, respectively,
segments distal and proximal from the treated area. Local
emetine perfusion significantly (*p < 0.05) decreased
BDNF expression in the treated area relative to other
segments of the same dendrite when CNQX was present
(n = 11 dendrites from 7 neurons), but not when vehicle
was applied to the bath (n = 9 dendrites from 6 neurons);
MAP2 expression in the same neurons was unaltered in
the treated area.
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BDNF as a State-Dependent Retrograde Messengerfailed to alter BDNF expression in neurofilament-positive axons
or GFAP-positive astrocytes (Figure 6F and Figure S8), indicating
that AMPAR blockade induces an increase in neuronal BDNF
expression that is specific to the dendritic compartment. More-
over, consistent with our biochemical data, the increase in
dendritic BDNF expression induced by AMPAR blockade was
due to de novo synthesis, given that it was prevented by the
translation inhibitors anisomycin and emetine (Figures 6F and
6G). Interestingly, blocking background spiking activity with
TTX did not prevent the ability of AMPAR blockade to enhance
dendritic BDNF expression in a protein synthesis-dependent
manner (Figure 6H), suggesting that blockade of AP-indepen-
dent miniature events are sufficient to drive changes in BDNF
synthesis. Hence, although the downstream consequences of
BDNF synthesis are gated by coincident activity in presynaptic
terminals, the synthesis of BDNF appears more tightly linked
with excitatory synaptic drive and the postsynaptic impact of
miniature synaptic transmission.
Previous studies have documented the importance of local
dendritic protein synthesis in forms of homeostatic plasticity
induced, in whole or part, by targeting postsynaptic receptors
with antagonists (Ju et al., 2004; Sutton et al., 2006; Aoto
et al., 2008). Thus, the increase in dendritic BDNF expression
could be due to localized dendritic synthesis or alternatively,
due to somatic synthesis and subsequent transport into
dendrites. It is well established that BDNF mRNA is localized
to dendrites (Tongiorgi et al., 1997; An et al., 2008) and that mini-(H) Mean (+ SEM) normalized dendritic expression of BDNF after AMPAR blockad
(TTX+CNQX); the same conditions were also examined with 30 min anisomycin (4
was used to identify dendrites. Both AMPAR blockade and AMPAR + AP bloc
enhanced dendritic BDNF expression in a protein synthesis-dependent fashion.
Neature synaptic events regulate dendritic translation efficiency
(Sutton et al., 2004), supporting the possibility that AMPAR
blockade induces local BDNF synthesis in dendrites. To examine
this possibility, we assessed the effects of locally blocking
protein synthesis in dendrites by using restricted microperfusion
of emetine during global AMPAR blockade. When locally admin-
istered 15 min prior to and throughout bath CNQX treatment
(40 mM; 60 min), emetine produced a selective decrease in
dendritic BDNF expression in the presence of coincident bath
CNQX application (Figure 7). Again, these local changes in
BDNF expression were specific, given that local administration
of emetine had no effect on MAP2 expression in the same
neurons, nor did local emetine have any effect on BDNF expres-
sion without coincident CNQX treatment (Figure 7D). These
results thus indicate that the selective increase in dendritic
BDNF expression induced by AMPAR blockade reflects local-
ized dendritic BDNF synthesis. Taken together, our results
suggest that AMPAR blockade induces local BDNF synthesis
in dendrites which, in turn, selectively drives state-dependent
compensatory increases in release probability from active
presynaptic terminals.
DISCUSSION
We have shown that different facets of synaptic activity play
unique roles in shaping the manner by which neurons homeo-
statically adjust pre- and postsynaptic function to compensatee (40 mMCNQX, 2 hr), AP blockade (2 mM TTX, 2 hr), or AMPAR + AP blockade
0 mM) pretreatment (28–42 DIV). Alexa555-conjugated phalloidin (1:200) signal
kade, but not AP blockade alone significantly (*p < 0.05, relative to control)
From left to right, n = 46, 39, 39, 38, 26, 22, 20, and 20 neurons.
uron 68, 1143–1158, December 22, 2010 ª2010 Elsevier Inc. 1153
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Figure 8. Parallel Roles for Dendritic Protein
Synthesis in Compensatory Presynaptic and Post-
synaptic Changes Induced by AMPAR Blockade
Model depicting key events underlying rapid homeostatic
compensation. AMPAR blockade induces rapid postsyn-
aptic compensation via synaptic incorporation of GluA1
homomeric AMPARs (Thiagarajan et al., 2005) that
emerges rapidly (<3 hr) and requires new protein
synthesis. Studies examining the effects of NMDAR mini
blockade have shown that the compensatory synaptic
incorporation of GluA1 homomers requires local dendritic
synthesis, likely of GluA1 itself (Ju et al., 2004; Sutton et al.,
2006; Aoto et al., 2008). These changes in GluA1 are
observed equally in the presence and absence of spiking
activity (Figure 1). In parallel, AMPAR blockade induces
rapid presynaptic compensation that requires coincident
activity in presynaptic terminals. The presynaptic changes
require the synthesis and release of BDNF, which is locally
translated in dendrites in response to AMPAR blockade.
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BDNF as a State-Dependent Retrograde Messengerfor acute loss of activity. In light of both the present findings and
prior studies, we propose the following working mechanistic
model (Figure 8) to explain the compensatory synaptic adapta-
tions that accompany blockade of excitatory synaptic drive.
AMPAR blockade induces two rapid and dissociable forms of
synaptic compensation: (1) a postsynaptic increase in expres-
sion of GluA2-lacking AMPARs and a corresponding enhance-
ment of mEPSC amplitude that is independent of background
spiking activity and (2) a retrograde enhancement of presynaptic
function that is driven by the convergence of BDNF-TrkB
signaling with AP-triggered Ca2+-influx through P/Q/N-type
channels. Whereas the postsynaptic changes are sensitive to
activity at either AMPARs or NMDARs, the enhancement in
presynaptic function is unique to loss of AMPAR activity. Both
pre- and postsynaptic changes require new protein synthesis,
but appear to depend on distinct dendritically synthesized
protein products—GluA1 synthesis is likely to be critical for rapid
postsynaptic compensation (Ju et al., 2004; Thiagarajan et al.,
2005; Sutton et al., 2006; Aoto et al., 2008), whereas BDNF
synthesis is critical for orchestrating retrograde compensatory
changes in presynaptic function.
Retrograde Homeostatic Modulation of Presynaptic
Function
Many studies have demonstrated postsynaptic forms of homeo-
static compensation associated with enhanced expression of
AMPARs at synapses (e.g., O’Brien et al., 1998; Wierenga
et al., 2005; Sutton et al., 2006). However, clear evidence for
homeostatic regulation of presynaptic neurotransmitter release
has also been documented (e.g., Bacci et al., 2001; Murthy
et al., 2001; Burrone et al., 2002; Thiagarajan et al., 2005;
Wierenga et al., 2006; Branco et al., 2008). Although methodo-
logical factors can contribute to this heterogeneity in expression1154 Neuron 68, 1143–1158, December 22, 2010 ª2010 Elsevier Inc.(Wierenga et al., 2006), previous examples of
retrograde effects of postsynaptic manipula-
tions on presynaptic structure (e.g., Pratt et al.,
2003) and function (e.g., Paradis et al., 2001;
Burrone et al., 2002; Frank et al., 2006) suggestthat intrinsic synaptic properties might also play a role. Indeed,
we find that in addition to rapid postsynaptic effects, AMPAR
blockade induces rapid (<3 hr) functional compensation in the
presynaptic compartment, an effect that is not observed with
either acute (3 hr) or chronic (24 hr) AP blockade (see also Bacci
et al., 2001). Not only was AP blockade insufficient to produce
changes in presynaptic function on its own, it also prevented
AMPAR blockade from producing those changes. Hence, the
compensatory increase in release probability induced by
AMPAR blockade is state dependent, requiring presynaptic
spiking and P/Q/N-type Ca2+-channel function during the period
of AMPAR blockade for its induction.
Our findings complement recent studies regarding retrograde
homeostatic regulation of presynaptic neurotransmitter release.
Frank and colleagues (2006) found that blocking spontaneous
neurotransmission at the Drosophila NMJ induced rapid
increases in presynaptic release probability; similar to our obser-
vations, they found that these changes were prevented by
mutations in the presynaptic Cav2.1 channel encoded by the
cacophony gene. The similar requirement for presynaptic
voltage-gated Ca2+ channels in the two studies suggests that
the state-dependent regulation of presynaptic function is evolu-
tionarily conserved. Another recent study using hippocampal
neurons (Branco et al., 2008) demonstrated that increases in
local dendritic activity homeostatically decrease release proba-
bility from presynaptic terminals terminating on that dendrite.
Our findings illustrate that the local homeostatic crosstalk
between postsynaptic signaling and presynaptic release proba-
bility also operates in the opposite direction, where loss of post-
synaptic activity selectively enhances release probability from
active presynaptic terminals. Finally, whereas our experiments
focus on presynaptic changes induced by loss of synaptic input,
data from Groth, Lindskog, Tsien, and colleagues suggest that
Neuron
BDNF as a State-Dependent Retrograde Messengerrestoration of synaptic drive after activity blockade may also
rapidly drive retrograde changes in release probability (Groth
et al., 2009, Soc. Neurosci. Abs.). Hence, recent work from
multiple groups establishes retrograde signaling as an important
homeostatic mechanism in neural circuits.
BDNF as a State-Dependent Retrograde Messenger
In our study, scavenging extracellular BDNF, blocking trkB acti-
vation, postsynaptic shRNA-mediated BDNF knockdown, and
direct BDNF application all point to BDNF as a retrograde
messenger linking postsynaptic consequences of AMPAR
blockade with sustained enhancement of presynaptic neuro-
transmitter release. These results are consistent with previous
studies showing that BDNF enhances presynaptic function
(e.g., Lessmann et al., 1994; Li et al., 1998; Schinder et al.,
2000; Tyler and Pozzo-Miller, 2001) via a direct influence of
BDNF signaling at the presynaptic terminal (Li et al., 1998;
Pereira et al., 2006). In addition to BDNF, recent studies have
demonstrated the importance of other releasable factors in
homeostatic adjustment of synaptic strength. Stellwagen and
Malenka (2006) demonstrated that glial-derived tumor-necrosis
factor alpha (TNF-a) can drive postsynaptic compensation in
neurons in response to chronic AP blockade. In our studies, glial
cells do not seem to be the source of BDNF responsible for
orchestrating presynaptic changes, given that AMPAR blockade
enhances BDNF synthesis in neuronal dendrites but does not
influence BDNF expression in astrocytes. Interestingly, however,
the role of TNF-a does seem to complement a more chronic role
for BDNF in slow homeostatic adjustment of synaptic strength
(Rutherford et al., 1998). In this study, cotreatment with BDNF
prevented the gradual scaling of mEPSC amplitude induced by
chronic TTX, whereas chronic treatment with a TrkB-IgG BDNF
scavenger mimicked the slow scaling induced by TTX. Together
with our results, these observations suggest that BDNF may
have multiple time-dependent roles in homeostatic synaptic
plasticity. Finally, a recent study (Aoto et al., 2008) has implicated
the release of retinoic acid (RA) in orchestrating the synaptic
incorporation of GluA2-lacking AMPARs to synapses induced
by blocking miniature neurotransmission. Interestingly, although
Aoto et al. (2008) demonstrate that RA mimics mini blockade
in driving protein synthesis-dependent postsynaptic recruitment
of GluA1 to synapses and enhancing mEPSC amplitude, it
had no effect on mEPSC frequency suggesting a selective
role in postsynaptic compensation. Together with our findings,
these results suggest that distinct releasable factors may be
engaged for homeostatic adjustment of pre- and postsynaptic
function.
Multiple Homeostatic Modes Control Postsynaptic
Function
For homeostatic forms of plasticity induced by coincident
blockade of APs and NMDARs, multiple studies have demon-
strated enhanced synthesis of GluA1 in dendrites (Ju et al.,
2004; Sutton et al., 2006) or synaptic fractions (Aoto et al.,
2008) and the incorporation of GluA2-lacking receptors at
synapses (Ju et al., 2004; Sutton et al., 2006; Aoto et al.,
2008). By contrast, blockade of APs alone induces a slower
form of postsynaptic compensation characterized by enhancedNeexpression of GluA2-containing AMPARs at synapses (Turri-
giano et al., 1998; Wierenga et al., 2005; Sutton et al., 2006),
possibly owing to a decrease in receptor removal and an accu-
mulation of existing synaptic receptors (e.g., O’Brien et al.,
1998; Ehlers, 2003; Ibata et al., 2008). These results support
the notion that spontaneous and AP-mediated neurotransmis-
sion engage unique signaling pathways in neurons (Sutton
et al., 2007; Atasoy et al., 2008) and that miniature synaptic
events in these neurons play an important role in the acute
homeostatic regulation of synaptic strength. Frank et al. (2006)
identified a similar role for spontaneous neurotransmission in
rapid homeostatic adjustment of synaptic function at the
Drosophila neuromuscular junction, suggesting that this role
for miniature events may be conserved across different synapse
classes and species. In a similar vein, Thiagarajan et al. (2005)
demonstrated the synaptic recruitment of GluA2-lacking
AMPARs in response to chronic (24 hr) AMPAR blockade, sug-
gesting that loss of AMPAR activity also engages mechanisms
that recruit GluA2-lacking AMPARs to synapses. Our results
extend these observations by demonstrating that AMPAR
blockade induces rapid postsynaptic recruitment of GluA1 that
is dependent on new protein synthesis. Moreover, we found
that regardless of the presence or absence of background
spiking, the increase in synaptic GluA1 and mEPSC amplitude
induced by AMPAR blockade is indistinguishable. These results
have two important implications. First, they demonstrate that
although AP blockade reveals the functional impact of miniature
neurotransmission (see also Sutton et al., 2006), this role extends
to conditions where background spiking is permissive. Second,
they suggest that the rapid implementation of these postsyn-
aptic changes is likely determined by changes in excitatory
synaptic drive rather than postsynaptic firing rate, given that
AP blockade alone induces a distinct set of postsynaptic
changes (i.e., enhanced expression of GluA2-containing
AMPARs) with far slower kinetics (>12 hr; Turrigiano et al.,
1998; Wierenga et al., 2005; Sutton et al., 2006). This notion is
further supported by the observation that spatially restricted
blockade of NMDAR miniature events enhances surface GluA1
expression locally (Sutton et al., 2006). Although these observa-
tions and some theoretical considerations (Rabinowitch and
Segev, 2008) argue for a local homeostatic mechanism, there
is also strong evidence for more global homeostatic control
mechanisms in neurons that may be tuned to firing rate
(Turrigiano et al., 1998). There are unique theoretical advantages
of global homeostatic mechanisms as well, particularly with
regard to preserving information coding capabilities of neurons
(Turrigiano, 2008). A recent study directly assessed the impact
of blocking postsynaptic firing by confining TTX treatment to
the postsynaptic cell body. Ibata et al. (2008) found such somatic
AP blockade induced a transcription-dependent accumulation
of GFP-tagged GluA2 at multiple sites throughout the dendritic
arbor remote from the perfusion site, indicative of a cell-wide
homeostatic mechanism. This transcription-dependent connec-
tion adds an interesting parallel with other evidence implicating
the immediate early gene Arc in global homeostatic control
(Shepherd et al., 2006) and also distinguishes this global
mechanism with transcription-independent synaptic insertion
of GluA2-lacking receptors that accompanies mini blockadeuron 68, 1143–1158, December 22, 2010 ª2010 Elsevier Inc. 1155
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the existence of multiple modes of homeostatic control in
neurons that are mediated by separate molecular pathways
and implemented over distinct spatial scales.
Dendritic BDNF Synthesis Drives Local Changes
in Presynaptic Function
Since the discovery of polyribosomes beneath synaptic sites on
dendrites, the hypothesis that dendritic protein synthesis can be
engaged to adjust synaptic composition on a local level has
received considerable attention. Our results indicate that in addi-
tion to allowing for fine spatial control over the postsynaptic
element, local dendritic synthesis may also actively participate
in controlling the function of apposed presynaptic terminals,
through local synthesis of BDNF and perhaps other retrograde
messengers. Thus, BDNF is both necessary and sufficient for
the state-dependent presynaptic changes induced by AMPAR
blockade, but acts downstream of protein synthesis. Further-
more, AMPAR blockade enhances dendritic BDNF expression
in a translation-dependent manner, and a local decrease in
dendritic BDNF expression accompanies spatially restricted
inhibition of dendritic protein synthesis when performed coinci-
dent with AMPAR blockade. This latter result suggests that the
mobility of the BDNF pool synthesized in response to AMPAR
blockade is restricted, although it is not presently clear what
mechanisms are responsible. Future studies examining dynamic
BDNF synthesis and trafficking in dendrites will be useful in eluci-
dating mechanisms that are responsible for this restricted
mobility. Importantly, preventing spiking in synaptic terminals
or the Ca2+ influx triggered by spiking completely prevents the
sustained presynaptic changes induced by BDNF, but does
not appear to affect the synthesis of BDNF directly. Hence, we
conclude that a dendritic source of BDNF participates in
enhancing release probability at apposed presynaptic sites,
but only at active terminals. It is now of interest to determine
how BDNF-driven signaling interacts with signaling driven by
AP-triggered Ca2+ influx in presynaptic terminals to mediate
this state-dependent enhancement of presynaptic function.
BDNF has received considerable attention for its role in long-
lasting synaptic plasticity and memory. Much of this interest is
driven by the fact that BDNF is known to potently regulate
neuronal translation generally (e.g., Takei et al., 2001), and local
translation in dendrites in particular (e.g., Aakalu et al., 2001; Yin
et al., 2002). Furthermore, there is substantial evidence that one
critical role of BDNF in long-term plasticity is for inducing trans-
lation, i.e., BDNF acts upstream of protein synthesis for certain
forms of LTP (e.g., Kang and Schuman, 1996; Messaoudi
et al., 2002; Tanaka et al., 2008). However, evidence has been
emerging that BDNF may play distinct roles downstream of
protein synthesis, presumably via its own translation (Pang
et al., 2004; Bekinschtein et al., 2007). Given that BDNF can
act both upstream and downstream of protein synthesis, a crit-
ical issue is what unique functional contributions BDNF might
make in these different roles. Collectively, our results suggest
one important aspect of BDNF’s role as a translation effector is
to orchestrate presynaptic changes in a state-dependent
manner. For homeostatic plasticity, this role of BDNF has the
important consequence of coordinating compensatory changes1156 Neuron 68, 1143–1158, December 22, 2010 ª2010 Elsevier Incat postsynaptic sites with corresponding increases in presyn-
aptic function. This specific rolemaywell extend beyond homeo-
static compensation, and the importance of BDNF as a transla-
tion effector in long-term potentiation (Pang et al., 2004) and
memory (Bekinschtein et al., 2007) could relate to its ability to
enhance presynaptic function in a state-dependent manner.
Although this notion remains speculative, the fact that active
presynaptic terminals are uniquely sensitive to BDNF’s effects
suggests that in other contexts, BDNF could provide feedback
to presynaptic terminals in a Hebbian fashion. In other words,
our results predict that inputs that are activated in an experi-
ence-dependent fashion, as might occur during repetitive
training trials, will be selectively strengthened via the state-
dependent enhancement of presynaptic function conferred by
BDNF. This type of mechanism could, in principle, allow for plas-
ticity mechanisms that are initially confined to the postsynaptic
compartment to engage appropriate synaptic contacts and drive
coordinate changes in their function so as to effectively match
efficacy on both sides of the synapse.
EXPERIMENTAL PROCEDURES
Cell Culture and Electrophysiology
All animal use followed NIH guidelines and was in compliance with the Univer-
sity of Michigan Committee onUse andCare of Animals. Dissociated postnatal
(P0-2) rat hippocampal neuron cultureswere prepared as previously described
(Sutton et al., 2006). mEPSCs were recorded from a holding potential
of – 70 mV with an Axopatch 200B amplifier from neurons bathed in HEPES-
buffered saline (HBS) containing: 119 mM NaCl, 5 mM KCl, 2 mM CaCl2,
2 mM MgCl2, 30 mM Glucose, 10 mM HEPES (pH 7.4) plus 1 mM TTX and
10 mM bicuculine; mEPSCs were analyzed with Synaptosoft minianalysis soft-
ware. For paired-pulse facilitation experiments, evoked EPSCs were elicited
with 0.3 ms pulses delivered by an extracellular bipolar stimulating electrode
positioned near the recorded neuron. All PPF experiments were conducted
in HBS with 0.5 CaCl2 and 3.5 MgCl2 within 15 min of CNQX or CNQX/TTX
washout. Whole-cell pipette internal solutions contained: 100 mM cesium
gluconate, 0.2 mM EGTA, 5 mM MgCl2, 2 mM ATP, 0.3 mM GTP, 40 mM
HEPES (pH 7.2). Statistical differences between experimental conditions
were determined by ANOVA and post-hoc Fisher’s LSD test.
BDNF shRNA Transfection
U6 promotor-driven scrambled and BDNF shRNA-expressing plasmids were
obtained from OriGene Technologies (Rockville, MD); BDNF shRNA 1: 50-TGT
TCCACCAGGTGAGAAGAGTGATGACC-3, BDNF shRNA 2: 50-GTGATGCTC
AGCAGTCAAGTGCCTTTGGA-30, scrambled: 50-GCACTACCAGAGCTAACT
CAGATAGTACT-30. Each plasmid additionally contains a tRFP expression
cassette driven by a distinct (pCMV) promoter. Neurons were transfected
with 0.5 mg of total DNAwith the CalPhos Transfection kit (ClonTech; Mountain
View, CA) according to the manufacturer’s protocol. All experiments were
performed 24 hr after transfection.
Western Blotting
Samples were collected in lysis buffer containing 100 mM NaCl, 10 mM
NaPO4, 10 mM Na4P2O7, 10 mM lysine, 5 mM EDTA, 5 mM EGTA, 50 mM
NaF, 1 mM NaVO3, 1% Triton-X, 0.1% SDS, and 1 tablet Complete Mini
protease inhibitor cocktail (Roche)/7 ml, pH 7.4. Equal amounts of protein
for each sample were loaded and separated on 12% polyacrylamide gels,
then transferred to PVDF membranes. Blots were blocked with Tris-buffered
saline containing 0.1% Triton-X (TBST) and 5% nonfat milk for 60 min at
RT, and incubated with a rabbit polyclonal primary antibody against
BDNF (Santa Cruz, 1: 200) for either 60 min at RT or overnight at 4C. After
washing with TBST, blots were incubated with HRP-conjugated anti-rabbit
secondary antibody (1:5000; Jackson Immunoresearch); this was followed.
Neuron
BDNF as a State-Dependent Retrograde Messengerby chemiluminescent detection (ECL, Amersham Biosciences). The same
blots were reprobed with a mouse monoclonal antibody against a-tubulin
(1:5000, Sigma) to confirm equal loading. Band intensity was quantified with
densitometry with NIH ImageJ and expressed relative to the matched control
sample. Statistical differences between treatment conditions and the control
were assessed by Chi square, whereas comparisons between CNQX and
CNQX + anisomycin were assessed with an unpaired t test (two-tailed).
Immunocytochemisty and Microscopy
Surface GluA1 (sGluA1) was labeled and imaged as described previously
(Sutton et al., 2006). Live-labeling (5 min) with an Oyster 550-conjugated rabbit
polyclonal antibody against the lumenal domain of synaptotagmin 1 (syt-lum;
1:100, Synaptic Systems) was used for assessing presynaptic function. Prior
to labeling, neurons were treated with 2 mM TTX for 15 min to isolate sponta-
neous neurotransmitter release. Synaptic terminals were identified in the same
samples with either a mouse monoclonal antibody against bassoon (1:1000,
Stressgen) or a guinea pig polyclonal vglut1 antibody (1: 2500, Chemicon).
For BDNF staining, cells were fixed on ice for 30 min with 4% paraformalde-
hyde (PFA)/4% sucrose in phosphate buffered saline with 1 mM MgCl2 and
0.1 mM CaCl2 (PBS-MC), permeabilized (0.1% Triton X in PBS-MC, 5 min),
blocked with 2% bovine serum albumin (BSA) in PBS-MC for 30 min, and
labeled with a rabbit polyclonal antibody against BDNF (Santa Cruz, 1:100).
For colabeling of dendrites, axons, and astrocytes, respectively, we used
the following: a mouse monoclonal antibody against MAP2 (Sigma, 1:5000),
a pan-axonal neurofilament mouse monoclonal antibody cocktail (1:8000,
clone SMI-312, Covance), and a mouse monoclonal antibody against GFAP
(Sigma, 1:1000). Secondary detection was achieved with Alexa 488-, 555-,
or 635-conjugated goat anti-rabbit or goat anti-mouse antibodies for 60 min
at RT.
All imaging was performed on an inverted Olympus FV1000 laser scanning
confocal microscope with identical acquisition parameters for each treatment
condition. Image analysis was performed on maximal intensity z-projected
images. For analysis of sGluA1 or syt-lum staining, a ‘‘synaptic’’ particle was
defined as occupying greater than 10% of the area defined by a PSD95 or
vglut1/bassoon particle. Analysis was performed with custom written analysis
routines for ImageJ. Statistical differences were assessed by ANOVA, then by
Fisher’s LSD post-hoc tests.
Local Perfusion
Stable microperfusion was achieved by use of a dual micropipette delivery
system, as described (Sutton et al., 2006). A cell-impermeant fluorescent
dye (either Alexa 488 or Alexa 555 hydrazide, 1 mg/ml) was included in the local
perfusate to visualize the affected area. In all local perfusion experiments, the
bath was maintained at 37C and continuously perfused at 1.5 ml/min with
HBS. For analysis, the size of the treated area was determined in each linear-
ized dendrite based on Alexa 488/555 fluorescence integrated across all
images taken during local perfusion. Adjacent nonoverlapping dendritic
segments, 25 mm in length, proximal and distal to the treated area were
assigned negative and positive values, respectively. For experiments exam-
ining local regulation of BDNF expression, the average nonzero pixel intensity
for the entire length of dendrite, excluding the treated area, was used for
normalizing BDNF intensity. For experiments examining syt-lum uptake,
immediately after local perfusion, 2 mM TTX was bath-applied for 10 min to
isolate spontaneous neurotransmitter release. Neurons were then live labeled
with anti-syt-lum for 5 min at RT and processed for immunocytochemistry as
described above. The density and intensity of vglut particles were calculated
for each dendritic segment, and the average value was then used for normal-
izing vlgut density and intensity in all segments (including the treated area). The
proportion of vglut particles with syt-lum particles was also determined in each
segment. Statistical differences were assessed by ANOVA and Fisher’s LSD
post-hoc tests.
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